Multiple Sclerosis: Therapies

Multiple Sclerosis is a demyelinating autoimmune disease of the central nervous system, resulting in symptoms including optic neuritis and motor weakness. The feed focuses on therapeutic interventions used to treat Multiple Sclerosis.

April 17, 2021

Targeting Adenosine Receptors in Neurological Diseases.

Cellular Reprogramming
Muhmmad AtifQaisar Raza
April 17, 2021

Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity.

Multiple Sclerosis and Related Disorders
Paolo De BlasiisGiacomo Lus
April 16, 2021

Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review.

American Journal of Clinical Dermatology
Akshitha ThatiparthiJashin J Wu
April 16, 2021
Review

Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention.

Food & Function
Yingying WangShanshan Ma
April 16, 2021

The "Managing Fatigue" programme - experiences shared by MS participants.

Scandinavian Journal of Occupational Therapy
Anna GillisdotterEva Månsson Lexell
April 16, 2021

Win odds: An adaptation of the win ratio to include ties.

Statistics in Medicine
Edgar BrunnerTobias Mütze
April 16, 2021

Disease Progression and Obstetric Outcomes of Women with Multiple Sclerosis at a Reference Center in Northeastern Brazil.

Revista brasileira de ginecologia e obstetrícia : revista da Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
Gabrielle Maria Carvalho de BarrosSabina Bastos Maia
April 16, 2021

Pregnancy outcomes in alemtuzumab treated women with multiple sclerosis: a case series.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Russo Cinzia ValeriaBrescia Morra Vincenzo
April 16, 2021
Open Access

Selective Endocannabinoid Reuptake Inhibitor WOBE437 Reduces Disease Progression in a Mouse Model of Multiple Sclerosis.

ACS Pharmacology & Translational Science
Ines Reynoso-MorenoAndrea Chicca
April 16, 2021
Review
Open Access

Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia.

Multiple Sclerosis and Related Disorders
Mohammed Al JumahSahar Shami
April 16, 2021

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.

Neurologia i neurochirurgia polska
Agata CzarnowskaHalina Bartosik-Psujek
April 16, 2021

Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy.

Multiple Sclerosis : Clinical and Laboratory Research
Elisabetta SignorielloAlessio Signori
April 16, 2021

Onychomycosis in patients with multiple sclerosis: prevalence, clinical description, mycological, and dermoscopic study in a Mexican population.

International Journal of Dermatology
Carlos D Sánchez-CárdenasTeresa Corona
April 16, 2021
Review
Open Access

Mesenchymal Stem Cells for Neurological Disorders.

Advanced Science
Anna AndrzejewskaMiroslaw Janowski
April 16, 2021
Review
Open Access

Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy.

Frontiers in Immunology
Cody D MoormanHyewon Phee
April 16, 2021
Open Access

Destination Amyotrophic Lateral Sclerosis.

Frontiers in Neurology
Matt KeonNitin K Saksena

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2021 Meta ULC. All rights reserved
/feed-previews/ms-therapies/8225165c-32ef-48e6-8979-3ff53ccb5b03